Links to Studies

Status Official Title Lead Investigator Last Updated
Finalised A real-life historic study assessing metabolic and other adverse effects of small versus large particle inhaled corticosteroids in relation to their clinical benefit in obstructive lung disease Miss Jessica Martin 11/09/2015
Finalised Effectiveness of prescribing similar vs dissimilar devices for COPD management (phase 1) Dr Arjun Jain 10/09/2015
Finalised State of the Union: Current asthma morbidity in the UK Dr Arjun Jain 26/08/2015
Finalised Increasing ICS Dose vs Add-on Therapy in Children with Asthma Professor Stephen Turner 31/07/2015
Finalised Metabolic effects associated with ICS (inhaled corticosteroid) use in COPD (chronic obstructive pulmonary disease) patients with type II diabetes Dr Rafael Mares 15/05/2015
Finalised Evaluation of patients with chronic obstructive pulmonary disease (COPD) and chronic kidney disease (CKD) who would benefit from aclidinium bromide treatment. Dr Emily Davis 25/03/2015
Finalised Comparative effectiveness and safety of Ipramol (ipratropium/albuterol) SteriNebs® vs. DuoNeb® Dr Rafael Mares 24/03/2015
Finalised Real-life effectiveness (and cost impact) evaluation of fixed-dose combination fluticasone propionate/formoterol (Flutiform®) for the management of asthma in a routine UK primary care population – Phase 2 Dr Daina Lim 17/03/2015
Finalised Real-life effectiveness (and cost impact) evaluation of fixed-dose combination fluticasone propionate/formoterol (Flutiform®) for the management of asthma in a routine UK primary care population - Phase 1 Dr Daina Lim 17/03/2015
Finalised Real-life effectiveness evaluation of the long-acting muscarinic antagonist aclidinium bromide (Eklira®) for the management of COPD in a routine UK primary care population - Study 1 Dr Lim Daina 17/03/2015
Finalised Real-world effectiveness of extrafine vesrus standard particle inhaled corticosteroids: A comparative effectiveness analysis of extrafine (EF) hydrofluoroalkane beclometasone (HFA-BDP) and Ciclesonide versus commonly prescribed standard particle inhaled corticosteroids for patients prescribed asthma therapy in The Netherlands. Dr Cristiana Miglio 21/01/2015
Finalised Characterising patients at risk of failed Diskus use in primary care Dr Emily Davis 24/11/2014
Ongoing Exploratory study identifying the benefits of pMDI versus Diskus for delivering fluticasone/salmeterol combination therapy in patients with chronic obstructive pulmonary disease (COPD) Miss Jessica Martin 11/03/2015
Planned Predictors of treatment choice in patients with COPD Professor David Price 06/07/2015